The MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease brand, founded in 2013 (United States), from 126 sister brands and 17479 competing brands. The MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease brand is owned by Celgene, a company listed in New York. MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease is part of the Drug Manufacturers activity sector.
